FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News

Court Hits FDA Discretion in Drug/Device Decisions

The DC Circuit Court of Appeals affirms a lower court decision that FDA is not afforded discretion when a combination product meets the definition of ...

Human Drugs

FDA Overreacted on J&J Vaccine Pause: Ex-Official

Pacific Research Institute senior fellow and former FDA Office of Biotechnology director Henry I. Miller says FDAs decision to recommend a pause on Jo...

Medical Devices

Tenacore Recalls Alaris Pumps Over Bezel Posts

Tenacore recalls Alaris Pumps it serviced because bezel repair posts may crack or separate leading to inaccurate fluid delivery.

Biologics

J&J Vaccine Maker Halts Production

Emergent BioSolutions, contract Covid-19 vaccine supplier to Johnson & Johnson, agrees to not manufacture bulk drug substances and to quarantine exist...

Medical Devices

FDA Hits Block Scientific Over Covid Products

FDA sends Block Scientific a Warning Letter after reviewing its Web site and determining it is marketing Covid-19 test kits without agency approval, c...

Federal Register

Some Software Functions Exempted from Device Definition

Federal Register final rule: FDA amends certain medical device classification regulations to exclude certain software functions from the definition of...

Federal Register

Latex Gloves Need 510(k); More Surveillance

Federal Register notice: FDA clarifies that despite enforcement discretion efforts during the Covid-19 pandemic, Class 1 surgeon and patient examinati...

Human Drugs

Opdivo OKd for Gastric Cancer

FDA approves Bristol-Myers Squibbs Opdivo (nivolumab) for combination use with chemotherapy for the initial treatment of patients with advanced or met...

Medical Devices

BD Recall of Alaris Pump Due to Keypad

Becton Dickinson recalls (Class 1) its CareFusion 303 Alaris Pump Module because of the risk of the keypad lifting up due to fluid entry.

Human Drugs

Lilly Asks FDA to Revoke EUA for Bamlanivimab Alone

Eli Lilly asks FDA to revoke its Emergency Use Authorization for bamlanivimab (LY-CoV555) 700 mg alone due to the growing prevalence of Covid-19 varia...